Xi-Fen Liu1,2, Lin-Ying Zhou1,2, Zi-Hao Wei1,3, Jia-Xin Liu1,2, Ang Li1,3, Xiao-Zhong Wang1, Hou-Qun Ying1. 1. Department of Clinical Laboratory, Jiangxi Province Key Laboratory of Laboratory Medicine, the second affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi, PR China. 2. Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, PR China. 3. Queen Mary School, Nanchang University, Nanchang 330006, Jiangxi, PR China.
Abstract
AIM: To investigate the diagnostic roles of circulating inflammatory biomarkers in gallbladder carcinoma (GBC). PATIENTS & METHODS: Circulating inflammatory cell count, fibrinogen, albumin, carcinoembryonic antigen (CEA) and CA199 were measured, neutrophil-to-lymphocyte ratio (NLR), dNLR, PLR, LMR and Alb-to-fib (AFR) were calculated in 306 GBC patients, 306 healthy and 305 benign controls. The reciever operating characteristic curve was used to determine diagnostic accuracy of them. RESULTS: The area under curves of combined AFR, dNLR and lymphocyte were 0.943 and 0.985 for diagnosis of GBC from healthy and polyp controls, area under curve of combined AFR, CEA and CA199 was 0.90 for diagnosis of GBC from the cholecystitis patients. CONCLUSION: Circulating AFR combined with lymphocyte and dNLR or CEA and CA199 could effectively distinguish GBC from the healthy and benign controls.
AIM: To investigate the diagnostic roles of circulating inflammatory biomarkers in gallbladder carcinoma (GBC). PATIENTS & METHODS: Circulating inflammatory cell count, fibrinogen, albumin, carcinoembryonic antigen (CEA) and CA199 were measured, neutrophil-to-lymphocyte ratio (NLR), dNLR, PLR, LMR and Alb-to-fib (AFR) were calculated in 306 GBC patients, 306 healthy and 305 benign controls. The reciever operating characteristic curve was used to determine diagnostic accuracy of them. RESULTS: The area under curves of combined AFR, dNLR and lymphocyte were 0.943 and 0.985 for diagnosis of GBC from healthy and polyp controls, area under curve of combined AFR, CEA and CA199 was 0.90 for diagnosis of GBC from the cholecystitispatients. CONCLUSION: Circulating AFR combined with lymphocyte and dNLR or CEA and CA199 could effectively distinguish GBC from the healthy and benign controls.